642
M. Grabarczyk et al. / Tetrahedron 72 (2016) 637e644
þ
4
.2. Organic synthesis
170.0 (C-9); HRMS (ESI): MH , found 271.1465. C15
71.1459.
2
H23ClO requires
2
The starting material, b-ionone (1), was purchased from Fluka.
All other products were obtained according to procedures de-
scribed below.
4.2.6. 10-(11-Bromoethyl)-7-(1,1,5-trimethylcyclohex-5-en-6-yl)di-
hydrofuran-2(3H)-one (6). Bromolactonization of acid 4 performed
4
2
according to the known procedure gave the title compound 5
(2.5 g, 74%) as a colorless oil; max(KBr) 2934, 1780, 1446, 1168,
) 0.98 (3H, s, CH -14), 1.09 (3H, s,
-15), 1.34e1.40 (1H, m, one of CH -2), 1.46e1.48 (1H, m, one of
-2), 1.53e1.58 (2H, m, CH -3), 1.62 (3H, d, J 6.2 Hz, CH -12), 1.68
-13), 1.95e2.01 (2H, m, CH -4), 2.75 (1H, dd, J 20.0,
2.6 Hz, H-8), 2.96 (2H, dd, J 20.0, 7.0 Hz, H-8), 2.94e3.01 (1H, m, H-
7), 4.30 (1H, dd, J 10.7, 10.0 Hz, H-10), 4.49 (1H, qd, J 10.0, 6.2 Hz, H-
11); (75.5 MHz, CDCl ): 19.1 (C-3), 20.9 (C-12), 21.1 (C-13), 28.2
4
(
CH
.2.1. (1,1,5-Trimethylcyclohex-5-en-6-yl)but-3-en-2-one
600 MHz, CDCl ) 1.05 (6H, s, CH -11, CH -12), 1.44e1.48 (2H, m,
-2), 1.57e1.65 (2H, m, CH -3), 1.74 (3H, d, J 0.8 Hz, CH -13), 2.06
-4), 2.28 (3H, s, CH -10), 6.08 (1H, d, J
(1).
d
H
n
ꢁ
1
3
3
3
998 cm
;
d
H
(600 MHz, CDCl
3
3
2
2
3
CH
CH
3
2
(
2H, dd, J 6.3, 6.1 Hz, CH
2
3
2
2
3
16.4 Hz, H-8), 7.25 (1H, dd, J 16.4, 0.7 Hz, H-7).
(3H, s, CH
3
2
1
4
.2.2. (1,1,5-Trimethylcyclohex-5-en-6-yl)but-3-en-2-ol (2). Lithium
aluminum hydride was used for the reduction of
according to the known procedure. The resulting the title com-
pound 2 (9.8 g, 97%) was characterized by the spectral data com-
b
-ionone
d
C
3
3
8
(C-15), 28.3 (C-14), 34.8 (C-4), 35.6 (C-6), 37.0 (C-8), 40.0 (C-2), 40.9
(C-7), 53.2 (C-10), 80.7 (C-11), 131.4 (C-1), 136.0 (C-5), 169.9 (C-9);
3
9
þ
parable with literature data:
n
max(KBr) 3360, 2926, 1457, 1361,
) 0.98 (6H, s, CH -12, CH -13), 1.31
-10),1.42e1.46 (2H, m, CH -2),1.55e1.61 (2H, m,
-3), 1.66 (3H, s, CH -11), 1.97 (2H, m, CH -4), 4.37 (1H, dd, J 6.6,
.3 Hz, H-9), 5.48 (1H, dd, J 15.9, 6.6 Hz, H-8), 6.05 (1H, d, J 15.9 Hz,
H-7).
HRMS (ESI): MH , found 315.0960. C15
H23BrO
2
requires 315.0954.
ꢁ1
1
060 cm
3H, d, J 6.3 Hz, CH
CH
;
d
H
(600 MHz, CDCl
3
3
3
(
3
2
4.2.7. 10-(11-Iodoethyl)-7-(1,1,5-trimethylcyclohex-5-en-6-yl)dihy-
2
3
2
drofuran-2(3H)-one (7). Iodolactonization of acid 4 according to the
4
2
6
known procedure gave the title compound 7 (1.98 g, 69%) as
ꢃ
a white solid, mp¼79e81 C;
n
max(KBr) 2928, 1782, 1457, 1159,
) 0.98 (3H, s, CH -14), 1.05 (3H, s,
-15), 1.37e1.42 (1H, m, one of CH -2), 1.46e1.49 (1H, m, one of
-2), 1.52e1.56 (2H, m, CH -3), 1.62 (3H, s, CH -13), 1.86 (3H, d, J
-12), 1.95e1.98 (2H, m, CH -4), 2.47 (1H, d, J 11.6 Hz, one
ꢁ1
1010 cm
;
d
H
(600 MHz, CDCl
3
3
4
.2.3. Ethyl (4E)-7-(1,5,5-trimethylcyclohex-5-en-6-yl)hex-4-enoate
CH
CH
3
2
(3). Alcohol 2 after Claisen rearrangement (orthoacetate modifi-
2
2
3
4
0
cation ) gave the title compound 3 (7.7 g, 61%) as a colorless liquid,
7.2 Hz, CH
of CH
of CH
H-10);
3
2
ꢁ1
n
D
1.4782;
CDCl ) 1.02 (6H, s, CH
.40e1.44 (2H, m, CH
m, CH -13), 1.64 (3H, d, J 6.3 Hz, CH
CH -4), 2.38 (1H, dd, J 15.2, 3.6 Hz, one of CH
5.2, 10.8 Hz, one of CH -11), 3.38e3.44 (1H, m, H-7), 4.14 (2H, q, J
.2 Hz, OCH CH ), 5.31e5.43 (1H, m, H-9), 5.53e5.56 (1H, m, H-8),
(75.5 MHz, CDCl ) 14.287 (OCH CH ),18.0 (C-13),19.5 (C-10), 21.5
C-3), 27.9 (C-15), 28.1 (C-14), 34.0 (C-4), 36.1 (C-1), 38.4 (C-7), 39.8
n
max(KBr): 2930, 1737, 1450, 1039 cm
-14, CH -15), 1.25 (3H, t, J 7.2 Hz, OCH
-2), 1.49e1.55 (2H, m, CH -3), 1.58e1.59 (3H,
-10), 1.89 (2H, dd, J 6.6, 5.7 Hz,
-11), 2.75 (1H, dd, J
;
d
H
(600 MHz,
2
-8), 2.93e2.95 (1H, m, H-7), 2.96 (1H, dd, J 21.6, 11.6 Hz, one
-8), 4.42 (1H, qd, J 7.2, 2.3 Hz, H-11), 4.51 (1H, dd, J 5.6, 2.3 Hz,
3
3
3
2
CH ),
3
2
1
2
2
d
C
(75.5 MHz, CDCl
3
) 19.2 (C-2), 20.8 (C-13), 21.7 (C-12), 28.7
3
3
(C-14), 29.4 (C-15), 29.3 (C-11), 34.4 (C-4), 36.0 (C-1), 38.2 (C-7),
2
2
38.7 (C-8), 88.5 (C-10), 131.2 (C-5), 139.0 (C-6), 175.8 (C-9); HRMS
þ
1
7
2
(ESI): MH , found 363.0821. C15
H23IO
2
requires 363.0815.
2
3
d
C
3
2
3
4.3. Biotransformation
(
(
C-2), 40.0 (C-11), 60.2 (OCH
2
CH
3
), 124.0 (C-9), 129.4 (C-6), 132.9 (C-
4.3.1. Microorganisms. The fungal strains which were used in this
study were obtained from a collection of the Institute of Biology
and Botany, Medical University, Wroc1aw: F. culmorum AM10, F.
avenaceum AM11, F. oxysporum AM13, F. tricinctum AM16, F. sem-
itectum AM20, Fusarium solani AM203, B. cinerea AM235, and
Beauveria bassiana AM278. All these strains are available in De-
partment of Chemistry, University of Environmental and Life Sci-
ences. The strains were cultivated on Sabouraud’s agar containing
0.5% of aminobac, 0.5% of peptone, 4% of glucose and 1.5% of agar
þ
8
C
), 138.8 (C-5), 173.2 (C-8); HRMS (ESI): MH , found 265.2168.
17 28 2
H O requires 265.2162.
4
.2.4. (4E)-7-(1,5,5-Trimethylcyclohex-5-en-6-yl)hex-4-enoic
acid
(4). Ester 3 subjected to basic hydrolysis according to the pro-
41
cedure described previously gave the title compound 4 (2.9 g, 75%)
ꢃ
as a white solid, mp 41e42 C;
n
max(KBr) 2930, 1701, 1430,
-14), 1.03 (3H, s,
-2), 1.50e1.54 (2H, m, CH -3), 1.58
-13), 1.66 (3H, d, J 6.3 Hz, CH -10), 1.88e1.92 (2H, m, CH
), 2.44 (1H, dd, J 15.7, 3.5 Hz, one of CH -11), 2.82 (1H, dd, J 15.7,
-11), 3.40e3.44 (1H, m, H-7), 5.37e5.47 (1H, m,
H-9), 5.54e5.61 (1H, m, H-8); (75.5 MHz, CDCl ) 18.0 (C-13), 19.4
C-10), 21.5 (C-3), 27.9 (C-15), 28.0 (C-14), 34.0 (C-4), 36.1 (C-1), 38.0
ꢁ1
1222 cm
;
d
H
(600 MHz, CDCl
3 3
) 1.02 (3H, s, CH
ꢃ
CH
3
-15), 1.40e1.44 (2H, m, CH
2
2
dissolved in distilled water at 28 C and stored in a refrigerator at
ꢃ
(
3H, s, CH
3
3
2
-
4 C.
4
2
10.8 Hz, one of CH
2
4.3.2. Screening procedure. The fungal strains which were used for
ꢃ
d
C
3
microbial transformations were cultivated at 25 C in 300 mL
(
(
Erlenmayer flasks filled with 100 mL of the medium containing 3 g
of glucose and 1 g of peptobac. After three days 10 mg of the sub-
strate dissolved in 1 mL of acetone was added to each flask of
culture. The shaken cultures were incubated with the substrate for
C-7), 39.3 (C-2), 40.0 (C-11), 124.2 (C-9), 129.7 (C-6), 132.7 (C-8),
ꢁ
138.7 (C-2), 178.5 (C-12); HRMS (ESI): MH found 235.1702.
C
H O
15 24 2
requires 235.1704.
7
days. After 3, 5 and 7 days of incubation, the mixture of unreacted
4
.2.5. 10-(11-Chloroethyl)-7-(1,1,5-trimethylcyclohex-5-en-6-yl)di-
substrate, products and mycelium was extracted with 15 mL of
dichloromethane. After evaporation of the solvent, the residue was
dissolved in 2 mL of acetone and analysed by TLC (silica gel, hex-
ane:acetone, 3:1) and GC (DB-17 column).
hydrofuran-2(3H)-one (5). Acid 4 subjected to the known pro-
cedure gave the title compound 5 (2.0 g, 69%) as a colorless oil;
4
2
ꢁ
1
n
max(KBr) 2931, 1786, 1455, 1142, 979 cm
.97 (3H, s, CH -14), 1.05 (3H, s, CH -15), 1.31e1.41 (2H, m, CH
.47e1.55 (2H, m, CH -3), 1.55 (3H, d, J 6.2 Hz, CH -12), 1.67 (3H, s,
CH -13), 1.97 (2H, dd, J 6.2, 6.0 Hz, CH -4), 2.74 (1H, dd, J 17.0,
.0 Hz, one of CH -8), 2.89e3.02 (1H, m, H-7), 2.98 (1H, dd, J 17.0,
.5 Hz, one of CH -8), 4.19 (1H, dd, J 10.6, 9.9 Hz, H-10), 4.38 (1H, qd,
J 9.9, 6.2 Hz, H-11); (75.5 MHz, CDCl ) 19. 2 (C-12), 19.9 (C-13),
1.1 (C-3), 28.0 (C-15), 29.2 (C-14), 34.6 (C-4), 35.6 (C-6), 36.7 (C-8),
;
d
H
(600 MHz, CDCl
3
)
0
1
3
3
2
-2),
2
3
4.3.3. Preparative transformations. 10 Erlenmeyer flasks with the 3-
day cultures of fungal strains were prepared as described in the
screening procedure. Then 100 mg of the halolactones 5e7 were
dissolved in 10 mL of acetone and distributed between these flasks.
After 7 days the products were extracted with dichloromethane
(3ꢂ40 mL). The combined organic solutions were dried over an-
hydrous magnesium sulfate and the solvent was evaporated in
3
2
9
7
2
2
d
C
3
2
4
0.0 (C-2), 40.6 (C-7), 60.6 (C-10), 80.3 (C-11), 87.5 (C-1),131.0 (C-5),